Atlas Trials

CD-RCHOP in ND DLBCL With a Combination of TP53 Mutation and Del(17p)

Clinical trial NCT06750991 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06750991
Sponsor
Ruijin Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
DLBCL
Start date
2024-12-31
Primary completion
2026-12-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.